Results 281 to 290 of about 43,753 (301)

Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model

Cancer Immunology, Immunotherapy, 2020
Philipp Metzger, Sabrina Viktoria Kirchleitner, Daniel F R Boehmer   +2 more
exaly  

Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

Cancer Immunology, Immunotherapy, 2013
Emanuela Romano, Daniel E Speiser, Olivier Michielin   +2 more
exaly  

Human MDSCs

2016
openaire   +1 more source

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression

Cancer Discovery, 2016
Guocan Wang, Xin Lu, Prasenjit Dey
exaly  

Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer

Frontiers in Immunology, 2019
Pamela L Beatty
exaly  

Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer

European Journal of Immunology, 2020
Ece Tavukcuoglu, Utku Horzum, Hamdullah Yanik   +2 more
exaly  

High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia

Cancers, 2020
Michał K Zarobkiewicz, Wioleta Kowalska, Sylwia Chocholska   +2 more
exaly  

Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy

Urologic Oncology: Seminars and Original Investigations, 2018
Moshe C Ornstein, Sarah Devonshire, Andrew Stephenson   +2 more
exaly  

Targeting MDSCs with LXR agonists

Nature Reviews Clinical Oncology, 2018
openaire   +1 more source

Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function

Frontiers in Immunology, 2018
Natascha Köstlin-Gille, Rangmar Goelz, Christian Poets   +2 more
exaly